drugset / Trial / NCT00610480
Tear Film Stability After Instillation of Over-the-Counter (OTC) Artificial Drops
RandomizedCrossoverOpen-labelTreatment
Summary
The goal of this research is to evaluate and compare the effectiveness of Systane® versus Optive™ on aqueous tear film stability in patients with a diagnosis of Dry Eye Syndrome and to determine the possible application for this product in the future. Systane® is marketed as over-the-counter tear lubricating therapy in the United States under the FDA monograph.
Timeline
- Start
- 2007-11
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Optive | Other / unclassified | 0.04 ml | Topical |
| Comparator | Systane | Other / unclassified | 0.04 ml | Topical |